| Clovis Oncology Switzerland GmbH - Rubraca 300 mg, Filmtabletten | | 67402 | | 03 | | Rubraca 300 mg | | Filmtabletten | | L01XK03 | | Rucaparib | | 26.11.2020 | | |
| | Zusammensetzung | | rucaparibum 300 mg ut rucaparibi camsilas, cellulosum microcristallinum, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 4000, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium max. 1.8 mg. | | Packungsbestandteile | | Filmtabletten | | | | | Wirkstoffe | Stärke |
|---|
| Rucaparibum | 300 mg |
| | BAG: Wirkstoffe | Stärke |
|---|
| Rucaparibum | 300 mg |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| (Flavum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 4000 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
